
The Match Game (4.14.2023)
Rheumnow Podcast
00:00
The Risks of Drug Discontinuation in RA Patients
There were significantly higher rates of major adverse cardiac events, ACS acute coronary syndromes, strokes, serious infections, herpes zoster, liver disease, and suicide. The discontinuation rate was higher with Abatassip, Inflict Somab, Golimimab, and Serdylismab. But lower on Tophocilismab or Toximab and Baracitinib.
Transcript
Play full episode